The beginning of a new era in medicine: The U.S. FDA has today approved cell-based gene therapy Casgevy, marking the first FDA-approved therapy utilising the genome editing technology CRISPR (NASDAQ:CRSP) | https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
#FDA #CRISPR #shorts
DY6
0.135
92.9%
EEL
0.001
-50%
LKY
0.042
82.6%
HCF
0.02
-44.4%
DTR
0.036
63.6%
DTM
0.003
-40%
DES
0.165
57.1%
MTB
0.003
-40%
HRE
0.029
52.6%
DYM
0.215
-34.8%
TMK
0.003
50%
JAV
0.002
-33.3%
WCN
0.034
47.8%
MIO
0.018
-33.3%
AZL
0.01
42.9%
VFX
0.002
-33.3%
YAR
0.007
40%
ANX
0.007
-30%
VRX
0.057
39%
IFG
0.005
-28.6%
WJL
0.895
37.7%
HLS
1.155
-26.2%
CMD
0.022
37.5%
XPN
0.015
-25%
VRL
0.022
37.5%
C29
0.035
-23.9%
BCB
0.475
33.8%
BB1
0.32
-21%
CRB
0.004
33.3%
1AD
0.004
-20%
GGE
0.004
33.3%
AVE
0.004
-20%
OSL
0.004
33.3%
PUR
0.037
-19.6%
PPY
0.012
33.3%
OPL
0.021
-19.2%
THB
0.012
33.3%
NWM
0.013
-18.8%
VEN
0.004
33.3%
EV1
0.009
-18.2%
